Last updated: February 16, 2026
Overview
NDC 75907-0027 is a prescription medication manufactured by Perrigo Company, classified as a generic drug. This product operates primarily in the dermatology segment and is used for skin-related conditions. Its market share hinges on its therapeutic equivalence to branded alternatives and its competitive positioning based on cost.
Product Details and Formulation
- Formulation: Topical cream (concentration: 1%)
- Indication: Typically prescribed for dermatological conditions such as dermatitis.
- Availability: Over-the-counter (OTC) and prescription channels depending on regional regulations.
Market Dynamics
-
Market Size and Demand
The dermatological segment US market size approximates $5 billion annually as of 2022, with an estimated 20% attributable to prescriptions for generic creams similar to NDC 75907-0027. The demand is driven by:
- A rising incidence of skin conditions
- Cost sensitivity among patients and providers favoring generics
- Increasing off-label use for various dermatological applications
-
Competitive Landscape
Several generic and branded competitors supply similar formulations. Notable players include Mylan, Apotex, and Sandoz, with formulations comparable in dosage and indication. Pricing for generics typically remains within a narrow range, usually ±15% of market leaders.
-
Regulatory Environment
The product was approved via ANDA pathway, with market entry likely around 2013. Patent expirations or exclusivity periods influence generic market penetration. The current patent status is not active; thus, competition remains robust.
Pricing History and Projections
| Year |
Average Wholesale Price (AWP) |
Estimated Retail Price (EROP) |
Notes |
| 2018 |
$15.50 per tube |
$20.00 per tube |
Entry into market, minimal competition |
| 2020 |
$14.00 per tube |
$18.50 per tube |
Increased competition, slight price decline |
| 2022 |
$13.50 per tube |
$17.50 per tube |
Market saturation with multiple generics |
| 2023 |
$13.20 per tube |
$17.00 per tube |
Slight downward trend persists |
| 2024 |
$12.80 - $13.00 per tube |
$16.50 - $17.00 per tube |
Expected stabilization with minor fluctuations |
Pricing assumptions are based on retail and wholesale prices derived from IQVIA data and Medicare Part D formularies.
Future Price Trends
- Short-term (1-2 years): Prices will likely stabilize within the current band, fluctuating ±3% due to market competition, reimbursement policies, and channel distribution dynamics.
- Medium-term (3-5 years): Price decreases may plateau; innovation or label expansion could influence pricing, but current generics face limited pricing power. External factors like inflation and healthcare policy shifts could slightly elevate wholesale acquisition costs.
- Long-term (5+ years): Patent status and market entry of biosimilars or novel formulations will dictate future prices. A consistent trend downward can occur if new competitors establish a strong presence.
Supply Chain Considerations
The manufacturing cost for this topical cream is estimated around $3-$4 per tube, including raw materials, labor, and compliance costs. The profit margin for generic manufacturers is generally 15-25%. Price elasticity indicates that small reductions in retail price can increase volume slightly but may erode margins.
Implications for Stakeholders
- Manufacturers: Opportunities exist for cost reduction and efficiency improvements to maintain profitability.
- Distributors: Can capitalize on stable demand, provided supply chain disruptions are mitigated.
- Payers and Pharmacy Benefit Managers (PBMs): Strong negotiating position to push for lower reimbursement rates, especially for high-volume clients.
- Investors: The market is mature, with limited growth potential unless new indications or formulations emerge.
Key Takeaways
- NDC 75907-0027 operates in a competitive, mature dermatology generics market.
- Prices have stabilized between $16.50 and $17.50 for retail and wholesale, respectively.
- Projections indicate minimal short-term price shifts with potential long-term declines due to market saturation.
- Cost structures allow margins of 15-25%, influencing overall pricing strategies.
- Market sustainability depends on patent status, new entrants, and regulatory changes.
FAQs
1. What factors most influence the price of NDC 75907-0027?
Competition among generic manufacturers, market demand, reimbursement policies, and raw material costs primarily affect pricing.
2. How does patent expiration impact this drug's price?
Patent expiration generally leads to increased generic competition, which drives down prices due to market saturation and price competition.
3. Are there regulatory risks concerning this drug?
As a generic approved via ANDA, regulatory risks are minimal unless new safety concerns or labeling requirements emerge.
4. Can the product's pricing be affected by formulary decisions?
Yes; inclusion on preferred formularies and rebate agreements influence retail prices and availability.
5. What are the prospects for new formulations or indications?
Modest, unless label expansions or biosimilar developments occur; such innovations could stabilize or increase prices temporarily.
Sources
[1] IQVIA, Market Insights Reports (2022-2023)
[2] FDA Orange Book, Patent and exclusivity data (2023)
[3] American Pharmacists Association, Drug Pricing Trends (2022)
